168 related articles for article (PubMed ID: 16038481)
1. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.
John M; Moore CB; James IR; Mallal SA
Antivir Ther; 2005; 10(4):551-5. PubMed ID: 16038481
[TBL] [Abstract][Full Text] [Related]
2. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
[TBL] [Abstract][Full Text] [Related]
3. Novel drug resistance mutations in HIV: recognition and clinical relevance.
Perno CF; Svicher V; Ceccherini-Silberstein F
AIDS Rev; 2006; 8(4):179-90. PubMed ID: 17219733
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of natural selection in the reverse transcriptase gene of HIV-1 in the presence and absence of antiretroviral therapy.
de S Leal E; Holmes EC; Zanotto PM
Virology; 2004 Aug; 325(2):181-91. PubMed ID: 15246258
[TBL] [Abstract][Full Text] [Related]
5. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.
Corvasce S; Violin M; Romano L; Razzolini F; Vicenti I; Galli A; Duca P; Caramma I; Balotta C; Zazzi M
Antivir Ther; 2006; 11(3):329-34. PubMed ID: 16759049
[TBL] [Abstract][Full Text] [Related]
6. Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.
Gatanaga H; Murakoshi H; Hachiya A; Hayashida T; Chikata T; Ode H; Tsuchiya K; Sugiura W; Takiguchi M; Oka S
Clin Infect Dis; 2013 Oct; 57(7):1051-5. PubMed ID: 23797286
[TBL] [Abstract][Full Text] [Related]
7. HIV evolution: CTL escape mutation and reversion after transmission.
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
[TBL] [Abstract][Full Text] [Related]
8. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
[TBL] [Abstract][Full Text] [Related]
9. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD
J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
[TBL] [Abstract][Full Text] [Related]
12. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
[TBL] [Abstract][Full Text] [Related]
13. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
[TBL] [Abstract][Full Text] [Related]
14. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
17. A model of directional selection applied to the evolution of drug resistance in HIV-1.
Seoighe C; Ketwaroo F; Pillay V; Scheffler K; Wood N; Duffet R; Zvelebil M; Martinson N; McIntyre J; Morris L; Hide W
Mol Biol Evol; 2007 Apr; 24(4):1025-31. PubMed ID: 17272680
[TBL] [Abstract][Full Text] [Related]
18. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
[TBL] [Abstract][Full Text] [Related]
19. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
20. Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.
Knapp DJ; Brumme ZL; Huang SY; Wynhoven B; Dong WW; Mo T; Harrigan PR; Brumme CJ
Clin Infect Dis; 2012 Jun; 54(11):1652-9. PubMed ID: 22460975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
